Recon: Kennedy defends HHS cuts in contentious hearing; FDA approves Amneal’s self-administered migraine therapy
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States